Ysios Capital Fund IV | 2026 VC Fund

Ysios Capital

cb Email

Status

ACTIVE

Global HQ

San Sebastian, Spain

Countries of investment

Spain
Portugal
France
Germany
Belgium
Switzerland
Netherlands
United States

Investment stages

Series A
Series B
Series C

Industries

Biotechnology
Life Sciences
Pharma
MedTech

About
Ysios Capital is one of Europe's leading biotech VCs founded in 2008. Their focus spans life sciences, medtech, and pharmaceuticals across Spain, Portugal, France, Germany, Belgium, Switzerland, and the US. The firm combines €450M+ AUM across three funds with offices in San Sebastián and Barcelona to support founders from Series A through C.

Min check size: $5.8M
Max check size: $23.4M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Ysios Capital is a Series A through C-focused biotech venture capital firm deploying capital across life sciences, medtech, and pharmaceuticals sectors. They invest in European biotech and medical device companies with strong scientific differentiation and clinical milestones. The firm differentiates itself through 17+ years of biotech specialization, one of Europe's strongest biotech track records (Sticres-Roche, Endosense-St. Jude, Palobiofarma-Novartis), and EIF/BEI institutional backing.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Ysios is led by seasoned biotech investors with deep expertise in drug development and regulatory pathways, positioning them as specialists in high-risk, high-reward healthcare investments.